Affiliation:
1. Unité des Rickettsies CNRS UPRES-A 6020, Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex 05, France
Abstract
ABSTRACT
The in vitro activity of moxifloxacin against
Coxiella burnetii
was compared to those of pefloxacin, ofloxacin, and doxycycline. MICs of moxifloxacin ranged from 0.5 to 1 μg/ml for the Nine Mile, Priscilla, and Q212 strains. Moxifloxacin was not bactericidal against
C. burnetii
at 4 μg/ml.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference18 articles.
1. Moxifloxacin.;Balfour J. A.;Drugs,1999
2. In Vitro Activity of BAY 12-8039, a New Fluoroquinolone, against Mycoplasmas
3. In vitro activity of Bay 12-8039, a new 8-methoxyquinolone
4. In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin.;Gikas A.;Antimicrob. Agents Chemother.,1999
5. Q fever is absent from New Zealand.;Kazar J.;Int. J. Epidemiol.,1993
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献